November 23, 2022 Regulatory Nomination Committee Appointed for the Annual General Meeting 2023 in Promore Pharma
November 1, 2022 Regulatory Promore Pharma provides an update on the Phase II clinical trial with ensereptide
June 13, 2022 Regulatory The last clinic visit conducted in Promore Pharma’s phase II study of ensereptide
June 13, 2022 Regulatory Sista klinikbesöket genomfört i Promore Pharmas fas II-studie av ensereptide
May 17, 2022 Regulatory Report from the Annual General Meeting of Promore Pharma AB held on 17 May 2022
March 17, 2022 Regulatory Promore Pharma has reached recruitment goal in clinical trial of ensereptide
February 16, 2022 Regulatory Första patient rekryterad till Promore Pharmas kliniska prövning rörande ärrbildning enligt plan
February 16, 2022 Regulatory First patient recruited to Promore Pharma’s clinical trial regarding scarring according to plan